Dichloro(ethylenediamine)platinum(II)
CAS: 14096-51-6
Ref. 3D-PAA09651
1g | 801,00 € | ||
2g | 1.160,00 € | ||
100mg | 194,00 € | ||
250mg | 364,00 € | ||
500mg | 517,00 € |
Informação sobre produto
- (SP-4-2)-Dichloro(1,2-ethanediamine-κN<sup>1</sup>,κN<sup>2</sup>)platinum
- Cpa 3
- Dichloro(1,2-diaminoethane)platinum
- Dichloro(1,2-ethanediamine)platinum
- Dichloro(ethane-1,2-diamine)platinum(II)
- Dichloroplatinum(2+) Ethane-1,2-Diyldiazanide
- Enplatin
- NSC 125181
- Platinum ethylenediamine dichloride
- Platinum(2+) Dichloride - Ethane-1,2-Diamine (1:1)
- Ver mais sinónimos
- Platinum, dichloro(1,2-ethanediamine-N,N′)-, (SP-4-2)-
- Platinum, dichloro(1,2-ethanediamine-κN,κN′)-, (SP-4-2)-
- Platinum, dichloro(1,2-ethanediamine-κN<sup>1</sup>,κN<sup>2</sup>)-, (SP-4-2)-
- Platinum, dichloro(ethylenediamine)-
- cis-Dichloro ethylenediammine platinum
- cis-Dichloro(ethylenediamine)platinum
- cis-Dichloro(ethylenediamine)platinum(Ⅱ)
Dichloro(ethylenediamine)platinum (II) is a platinum-based anticancer drug that is used in the treatment of ovarian cancer. It binds to the phosphate group of DNA and forms a chelate ring with the DNA. This inhibits the cellular function of the DNA, preventing replication and transcription. The dichloro(ethylenediamine)platinum (II) molecule has two possible stereoisomers: cis-dichloro(ethylenediamine)platinum (II) or trans-dichloro(ethylenediamine)platinum (II). The cis form is more active than the trans form, but both are equally effective in inhibiting DNA synthesis. Dichloro(ethylenediamine)platinum (II) also reacts with chloride ions to form an ion pair complex that is taken up by cells. This complex disrupts cell metabolism and leads to apoptosis.
Propriedades químicas
Consulta técnica sobre: 3D-PAA09651 Dichloro(ethylenediamine)platinum(II)
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.